Breakthrough Cholesterol Drug Lipfendra Wins FDA Approval
The U.S. Food and Drug Administration (FDA) has approved Lipfendra, a new cholesterol-lowering medication designed to help patients manage high cholesterol levels. The approval marks a significant development in cardiovascular care, giving doctors and patients another potential option for reducing harmful cholesterol and lowering the risk of heart-related complications. High cholesterol remains one of the … Read more